Racial Variation in Willingness to Trade Financial Resources for Life-Prolonging Cancer Treatment

被引:18
|
作者
Martin, Michelle Y. [1 ]
Pisu, Maria
Oster, Robert A.
Urmie, Julie M. [2 ]
Schrag, Deborah [3 ]
Huskamp, Haiden A. [4 ]
Lee, Jeannette [5 ]
Kiefe, Catarina I. [6 ]
Fouad, Mona N.
机构
[1] Univ Alabama, Dept Med, Div Prevent Med, Sch Med, Birmingham, AL 35294 USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[5] Univ Arkansas, Dept Biostat, Little Rock, AR 72204 USA
[6] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA
关键词
treatment; preferences; cancer; race; financial resources; tradeoffs; CARE OUTCOMES RESEARCH; OF-LIFE; TREATMENT PREFERENCES; ETHNIC-DIFFERENCES; AFRICAN-AMERICAN; ADVANCE DIRECTIVES; WHITE PATIENTS; END; ATTITUDES; SUPPORT;
D O I
10.1002/cncr.25839
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Minority patients receive more aggressive care at the end of life, but it is unclear whether this trend is consistent with their preferences. We compared the willingness to use personal financial resources to extend life among white, black, Hispanic, and Asian cancer patients. METHODS: Patients with newly diagnosed lung or colorectal cancer participating in the Cancer Care Outcomes Research and Surveillance observational study were interviewed about myriad aspects of their care, including their willingness to expend personal financial resources to prolong life. We evaluated the association of race/ethnicity with preference for life-extending treatment controlling for clinical, sociodemographic, and psychosocial factors using logistic regression. RESULTS: Among patients (N = 4214), 80% of blacks reported a willingness to spend all resources to extend life, versus 54% of whites, 69% of Hispanics, and 72% of Asians (P<.001). In multivariate analyses, blacks were more likely to opt for expending all financial resources to extend life than whites (odds ratio, 2.41; 95% confidence interval, 1.84-3.17; P < .001). CONCLUSIONS: Black cancer patients are more willing to exhaust personal financial resources to extend life. Delivering quality cancer care requires an understanding of how these preferences impact cancer care and outcomes. Cancer 2011;117:3476-84. (C) 2011 American Cancer Society.
引用
收藏
页码:3476 / 3484
页数:9
相关论文
共 50 条
  • [31] Differences by Race, Religiosity, and Mental Health in Preferences for Life-Prolonging Treatment Among Medicare Beneficiaries
    Justin J. Sanders
    Anna I. Berrier
    Léonce Nshuti
    James A. Tulsky
    Charlotta Lindvall
    Journal of General Internal Medicine, 2019, 34 : 1981 - 1983
  • [32] Religious Coping and Use of Intensive Life-Prolonging Care Near Death in Patients With Advanced Cancer
    Phelps, Andrea C.
    Maciejewski, Paul K.
    Nilsson, Matthew
    Balboni, Tracy A.
    Wright, Alexi A.
    Paulk, M. Elizabeth
    Trice, Elizabeth
    Schrag, Deborah
    Peteet, John R.
    Block, Susan D.
    Prigerson, Holly G.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (11): : 1140 - 1147
  • [33] Elders' Preferences for Life-Prolonging Treatment and Their Proxies' Substituted Judgment: Influence of the Elders' Current Health
    Winter, Laraine
    Parks, Susan M.
    JOURNAL OF AGING AND HEALTH, 2012, 24 (07) : 1157 - 1178
  • [34] Differences by Race, Religiosity, and Mental Health in Preferences for Life-Prolonging Treatment Among Medicare Beneficiaries
    Sanders, Justin J.
    Berrier, Anna I.
    Nshuti, Leonce
    Tulsky, James A.
    Lindvall, Charlotta
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (10) : 1981 - 1983
  • [35] Docetaxel Activity in the Era of Life-prolonging Hormonal Therapies for Metastatic Castration-resistant Prostate Cancer
    Francini, Edoardo
    Sweeney, Christopher J.
    EUROPEAN UROLOGY, 2016, 70 (03) : 410 - 412
  • [36] Preparation of Mouse Model of Orthotopic Implantation of Human Pancreatic Cancer Cells and Life-Prolonging Effect of Gemcitabine
    Nozaki, Yuji
    Higuchi, Tamami
    Naito, Tomoharu
    Nakajima, Kota
    Okawa, Yoshifumi
    Ikuma, Hatsumi
    Kakinuma, Chihaya
    Ochiai, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S179 - S179
  • [37] Coping with cancer: Associations between coping methods and use of intensive life-prolonging care near death
    Phelps, A. C.
    Maciejewski, P. K.
    Nilsson, M.
    Balboni, T. A.
    Wright, A. A.
    Trice, E.
    Block, S. D.
    Prigerson, H. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Autonomy at the end of life: life-prolonging treatment in nursing homes-relatives' role in the decision-making process
    Dreyer, A.
    Forde, R.
    Nortvedt, P.
    JOURNAL OF MEDICAL ETHICS, 2009, 35 (11) : 672 - 677
  • [39] THE APPLETON INTERNATIONAL-CONFERENCE - DEVELOPING GUIDELINES FOR DECISIONS TO FORGO LIFE-PROLONGING MEDICAL-TREATMENT
    STANLEY, JM
    GILLETT, G
    BRODY, H
    STEINBERG, A
    JOURNAL OF MEDICAL ETHICS, 1992, 18 : S3 - S5
  • [40] Issues concerning life-prolonging treatment in Japan, as considered from attitudes among the legal and medical professions
    Iijima, Yoshihiko
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (01): : 139 - 147